Forma Therapeutics Holdings, Inc. announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2020. For the quarter, the company reported loss from operations was $32,240,000 against $30,985,000 a year ago. Net loss was $27,616,000 against $30,985,000 a year ago. Diluted per share was $0.67. For the nine months, the company reported loss from operations was $68,355,000 against $11,354,000 a year ago. Net loss was $41,826,000 against $10,137,000 a year ago. Diluted per share was $2.74.